# Deltex Medical Group plc Release and first sale of HD-ICG in France

- Link: https://www.directorstalkinterviews.com/deltex-medical-group-plc-release-first-sale-hd-icg-france/412735822
- Published: 2017-09-21T07:29:52+01:00
- Author: Giles Arbor

**Deltex Medical Group plc** (LON:DEMG), the global leader in oesophageal Doppler
monitoring (“ODM”) today announced the release and first sales of its new High Definition
Impedance Cardiography (HD-ICG) modality in France.

The Company released the French language version of the HD-ICG module on its CardioQ-
ODM+ haemodynamic monitoring platform earlier this month and supported clinical 
demonstrations to key opinion leaders in France. Following the success of these 
evaluations, the Company’s distributor in France has placed a small initial order,
purchasing two HD-ICG consoles for demonstration purposes.

HD-ICG provides a continuous indirect, non-invasive measurement of central blood
flow using disposable single patient sensor sets. The sensors are connected to the
Deltex CardioQ-ODM+ platform via a small console which also provides power; values
are displayed on specially designed screens on the Deltex monitor. It is ideally
suited to awake patients in both critical care and surgery who do not tolerate ODM
probes.

The Company expects to make margins of around 35% to 40% on sales to European distributors
of both HD-ICG consoles and subsequent disposable sensor sets.

> **Ewan Phillips, Deltex Medical Group Plc Chief Executive, commented:** “We are
> delighted to have made the first sales of our HD-ICG module into France, which
> is, by volume of patients treated, our largest export market. We plan to release
> this new module into additional select overseas markets over the remainder of 
> the year.”

Share on: